ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Agilent Technologies has agreed to acquire BioTek Instruments for a net price after tax benefits of about $1.05 billion. Based in Winooski, Vermont, BioTek produces cell-imaging systems, microplate readers, washers, and other tools for live cell analysis. It had sales last year of $162 million. Agilent entered the cell-analysis business in 2015 with the purchase of Seahorse Bioscience and later acquired two other firms in the field.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X